{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T14:24:17Z","timestamp":1780669457418,"version":"3.54.1"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalimaging.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Imaging"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.clinimag.2021.12.007","type":"journal-article","created":{"date-parts":[[2021,12,24]],"date-time":"2021-12-24T11:14:42Z","timestamp":1640344482000},"page":"56-64","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Primary peritoneal serous carcinoma: a primer for radiologists"],"prefix":"10.1016","volume":"83","author":[{"given":"Jonathan","family":"Gan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackson","family":"Herzog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Kikano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sree H.","family":"Tirumani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil H.","family":"Ramaiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.clinimag.2021.12.007_bb0005","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0002-9378(59)90287-X","article-title":"Mesothelioma of the pelvic peritoneum resembling papillary cystadenocarcinoma of the ovary; case report","volume":"77","author":"Swerdlow","year":"1959","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.clinimag.2021.12.007_bb0010","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1146\/annurev-pathol-020712-163949","article-title":"Origin and pathogenesis of pelvic (ovarian, tubal, and primary peritoneal) serous carcinoma","volume":"9","author":"Nik","year":"2014","journal-title":"Annu Rev Pathol"},{"issue":"4","key":"10.1016\/j.clinimag.2021.12.007_bb0015","doi-asserted-by":"crossref","first-page":"923","DOI":"10.2214\/ajr.183.4.1830923","article-title":"Serous surface papillary carcinoma of the peritoneum: clinical, radiologic, and pathologic findings in 11 patients","volume":"183","author":"Morita","year":"2004","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"10.1016\/j.clinimag.2021.12.007_bb0020","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1158\/1055-9965.EPI-08-0771","article-title":"Incidence of ovarian, peritoneal, and fallopian tube carcinomas in the United States, 1995\u20132004","volume":"18","author":"Goodman","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"40","key":"10.1016\/j.clinimag.2021.12.007_bb0025","article-title":"Differences between primary peritoneal serous carcinoma and advanced serous ovarian carcinoma: a study based on the SEER database","volume":"14","author":"Li","year":"2021","journal-title":"J Ovarian Res"},{"issue":"2","key":"10.1016\/j.clinimag.2021.12.007_bb0030","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1006\/gyno.1998.5090","article-title":"Prognostic factors in extraovarian primary peritoneal carcinoma","volume":"71","author":"Eltabbakh","year":"1998","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.clinimag.2021.12.007_bb0035","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1006\/gyno.1996.0060","article-title":"Primary peritoneal serous papillary carcinoma: a study of 25 cases and comparison with stage III-IV ovarian papillary serous carcinoma","volume":"60","author":"Ben-Baruch","year":"1996","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.clinimag.2021.12.007_bb0040","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s12253-011-9375-x","article-title":"Primary peritoneal serous papillary carcinoma: a clinical and pathological study","volume":"17","author":"Liu","year":"2011","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.clinimag.2021.12.007_bb0045","unstructured":"National Comprehensive Cancer Network NCCN clinical practice guidelines in oncology. Ovarian cancer including fallopian tube cancer and primary peritoneal cancer. NCCN Guidelines version 1.2021 https: \/\/www.nccn.org\/professionals\/physician_gls\/pdf\/ovarian.pdf. Accessed 5 May 2021."},{"issue":"1","key":"10.1016\/j.clinimag.2021.12.007_bb0050","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0090-8258(03)00068-4","article-title":"Extraovarian peritoneal serous papillary carcinoma: a phase II trial of cisplatin and cyclophosphamide with comparison to a cohort with papillary serous ovarian carcinoma - a gynecologic oncology group study","volume":"89","author":"Bloss","year":"2003","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.clinimag.2021.12.007_bb0055","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00595-013-0500-1","article-title":"Photodynamic detection and management of intraperitoneal spreading of primary peritoneal papillary serous carcinoma in a man: report of a case","volume":"44","author":"Canbay","year":"2014","journal-title":"Surg Today"},{"key":"10.1016\/j.clinimag.2021.12.007_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ehpc.2016.12.003","article-title":"Primary peritoneal low-grade serous carcinoma in a man: a case report and review of the literature","volume":"9","author":"Xu","year":"2017","journal-title":"Hum Pathol Case Rep"},{"issue":"7","key":"10.1016\/j.clinimag.2021.12.007_bb0065","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/ijc.23287","article-title":"Serous ovarian, fallopian tube and primary peritoneal cancers: a comparative epidemiological analysis","volume":"122","author":"Jordan","year":"2008","journal-title":"Int J Cancer"},{"issue":"7","key":"10.1016\/j.clinimag.2021.12.007_bb0070","first-page":"991","article-title":"Primary peritoneal and ovarian cancers: an epidemiological comparative analysis","volume":"21","author":"Grant","year":"2010","journal-title":"Cancer Causes Control"},{"issue":"11","key":"10.1016\/j.clinimag.2021.12.007_bb0075","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/jnci\/90.11.841","article-title":"Molecular evidence for multifocal papillary serous carcinoma of the peritoneum in patients with germline BRCA1 mutations","volume":"90","author":"Schorge","year":"1998","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"10.1016\/j.clinimag.2021.12.007_bb0080","first-page":"1361","article-title":"BRCA1-related papillary serous carcinoma of the peritoneum has a unique molecular pathogenesis","volume":"60","author":"Schorge","year":"2000","journal-title":"Cancer Res"},{"issue":"22","key":"10.1016\/j.clinimag.2021.12.007_bb0085","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.1200\/JCO.2003.04.131","article-title":"Fallopian tube and primary peritoneal carcinomas associated with BRCA mutations","volume":"21","author":"Levine","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clinimag.2021.12.007_bb0090","article-title":"Risk-reducing bilateral salpingo-oophorectomy for ovarian cancer: a review and clinical guide for hereditary predisposition genes","author":"Liu","year":"2021","journal-title":"J Oncol Pract"},{"key":"10.1016\/j.clinimag.2021.12.007_bb0095","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/1870834","article-title":"Primary peritoneal cancer two decades after a bilateral salpingo-oophorectomy","author":"Rodowa","year":"2019","journal-title":"Case Rep Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.clinimag.2021.12.007_bb0100","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1006\/gyno.2000.6095","article-title":"A genetic epidemiological study of carcinoma of the fallopian tube","volume":"80","author":"Aziz","year":"2001","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.clinimag.2021.12.007_bb0105","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/00006254-197203000-00001","article-title":"The secondary M\u00fcllerian system","volume":"27","author":"Lauchlan","year":"1972","journal-title":"Obstet Gynecol Surv"},{"issue":"25","key":"10.1016\/j.clinimag.2021.12.007_bb0110","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1200\/JCO.2008.16.4814","article-title":"Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention","volume":"26","author":"Carlson","year":"2008","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.clinimag.2021.12.007_bb0115","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ygyno.2010.11.020","article-title":"\"Primary peritoneal\" high-grade serous carcinoma is very likely metastatic from serous tubal intraepithelial carcinoma: assessing the new paradigm of ovarian and pelvic serous carcinogenesis and its implications for screening for ovarian cancer","volume":"120","author":"Seidman","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.clinimag.2021.12.007_bb0120","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/1097-0142(19950801)76:3<429::AID-CNCR2820760313>3.0.CO;2-8","article-title":"Papillary serous carcinoma of the peritoneum in women. A clinicopathologic and immunohistochemical study","volume":"76","author":"Zhou","year":"1995","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.clinimag.2021.12.007_bb0125","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/oem.2006.030155","article-title":"Tumours of the serosal membranes. Armed forces institute of pathology atlas of tumour pathology, fourth series, fascicle 3","volume":"64","author":"Gibbs","year":"2007","journal-title":"Occup Environ Med"},{"issue":"1","key":"10.1016\/j.clinimag.2021.12.007_bb0130","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0046-8177(90)90081-F","article-title":"Serous surface carcinoma of the peritoneum: a clinicopathologic study of 22 cases","volume":"21","author":"Truong","year":"1990","journal-title":"Hum Pathol"},{"issue":"3","key":"10.1016\/j.clinimag.2021.12.007_bb0135","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1365-2559.2005.02194.x","article-title":"Metastatic neoplasms involving the ovary: a review with an emphasis on morphological and immunohistochemical features","volume":"47","author":"McCluggage","year":"2005","journal-title":"Histopathology"},{"key":"10.1016\/j.clinimag.2021.12.007_bb0140","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/1752-1947-1-150","article-title":"Immunohistochemical identification of primary peritoneal serous cystadenocarcinoma mimicking advanced colorectal carcinoma: a case report","volume":"1","author":"von Riedenauer","year":"2007","journal-title":"J Med Case Rep"},{"issue":"2","key":"10.1016\/j.clinimag.2021.12.007_bb0145","first-page":"63","article-title":"Accuracy of the ADNEX MR scoring system based on a simplified MRI protocol for the assessment of adnexal masses","volume":"24","author":"Pereira","year":"2018","journal-title":"Diagn Interv Radiol"},{"issue":"5S","key":"10.1016\/j.clinimag.2021.12.007_bb0150","doi-asserted-by":"crossref","first-page":"S198","DOI":"10.1016\/j.jacr.2018.03.015","article-title":"ACR appropriateness criteria staging and follow-up of ovarian cancer","volume":"15","author":"Kang","year":"2018","journal-title":"J Am Coll Radiol"},{"issue":"2","key":"10.1016\/j.clinimag.2021.12.007_bb0155","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ijgo.2008.02.019","article-title":"Preoperative evaluation of pelvic masses with combined 18F-fluorodeoxyglucose positron emission tomography and computed tomography","volume":"102","author":"Yamamoto","year":"2008","journal-title":"Int J Gynaecol Obstet"},{"issue":"8","key":"10.1016\/j.clinimag.2021.12.007_bb0160","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/MNM.0b013e3281afa256","article-title":"Diagnostic accuracy of 18F-FDG PET\/CT in characterizing ovarian lesions and staging ovarian cancer: correlation with transvaginal ultrasonography, computed tomography, and histology","volume":"28","author":"Castellucci","year":"2007","journal-title":"Nucl Med Commun"},{"issue":"5","key":"10.1016\/j.clinimag.2021.12.007_bb0165","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00404-014-3364-8","article-title":"The new FIGO staging system for ovarian, fallopian tube, and primary peritoneal cancer","volume":"290","author":"Zeppernick","year":"2014","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.clinimag.2021.12.007_bb0170","series-title":"AJCC cancer staging manual","author":"Amin","year":"2017"},{"issue":"3","key":"10.1016\/j.clinimag.2021.12.007_bb0175","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1006\/gyno.1993.1223","article-title":"Extraovarian peritoneal serous papillary carcinoma: a case-control retrospective comparison to papillary adenocarcinoma of the ovary","volume":"50","author":"Bloss","year":"1993","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1016\/j.clinimag.2021.12.007_bb0180","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/uog.2587","article-title":"Transvaginal sonographic features of peritoneal carcinomatosis","volume":"26","author":"Savelli","year":"2005","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.clinimag.2021.12.007_bb0185","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1148\/rg.233025105","article-title":"Multidetector CT of peritoneal carcinomatosis from ovarian cancer","volume":"23","author":"Pannu","year":"2003","journal-title":"Radiographics"},{"issue":"1","key":"10.1016\/j.clinimag.2021.12.007_bb0190","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1102\/1470-7330.2011.0016","article-title":"CT, MRI and PET imaging in peritoneal malignancy","volume":"11","author":"Patel","year":"2011","journal-title":"Cancer Imaging"},{"issue":"4","key":"10.1016\/j.clinimag.2021.12.007_bb0195","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s13193-016-0539-8","article-title":"Role of imaging in peritoneal surface malignancies","volume":"7","author":"Krishnamurthy","year":"2016","journal-title":"Indian J Surg Oncol"},{"issue":"6","key":"10.1016\/j.clinimag.2021.12.007_bb0200","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s00261-003-0038-6","article-title":"Peritoneal serous papillary carcinoma: a reappraisal of CT imaging features and literature review","volume":"28","author":"Chiou","year":"2003","journal-title":"Abdom Imaging"},{"issue":"3","key":"10.1016\/j.clinimag.2021.12.007_bb0205","doi-asserted-by":"crossref","first-page":"687","DOI":"10.2214\/ajr.171.3.9725296","article-title":"CT appearance of primary papillary serous carcinoma of the peritoneum","volume":"171","author":"Stafford-Johnson","year":"1998","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"10.1016\/j.clinimag.2021.12.007_bb0210","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/00004728-200005000-00007","article-title":"Primary papillary serous carcinoma of the peritoneum: CT-pathologic correlation","volume":"24","author":"Chopra","year":"2000","journal-title":"J Comput Assist Tomogr"},{"issue":"2","key":"10.1016\/j.clinimag.2021.12.007_bb0215","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1148\/rg.282075175","article-title":"From the archives of the AFIP: primary peritoneal tumors: imaging features with pathologic correlation","volume":"28","author":"Levy","year":"2008","journal-title":"Radiographics"},{"issue":"1","key":"10.1016\/j.clinimag.2021.12.007_bb0220","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s002619900446","article-title":"Peritoneal serous papillary carcinoma: radiological appearance","volume":"24","author":"Furukawa","year":"1999","journal-title":"Abdom Imaging"},{"issue":"3","key":"10.1016\/j.clinimag.2021.12.007_bb0225","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1148\/rg.2016150130","article-title":"Extrauterine pelvic serous carcinomas: current update on pathology and cross-sectional imaging findings","volume":"36","author":"Katabathina","year":"2016","journal-title":"Radiographics"},{"key":"10.1016\/j.clinimag.2021.12.007_bb0230","doi-asserted-by":"crossref","first-page":"923","DOI":"10.2214\/ajr.183.4.1830923","article-title":"Serous surface papillary carcinoma of the peritoneum: clinical, radiologic, and pathologic findings in 11 patients","volume":"183","author":"Morita","year":"2004","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"10.1016\/j.clinimag.2021.12.007_bb0235","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ejrad.2008.02.019","article-title":"CA 125, PET alone, PET-CT, CT and MRI in diagnosing recurrent ovarian carcinoma: a systematic review and meta-analysis","volume":"71","author":"Gu","year":"2008","journal-title":"Eur J Radiol"},{"issue":"8","key":"10.1016\/j.clinimag.2021.12.007_bb0240","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/RLU.0b013e318299609f","article-title":"PET or PET\/CT for detection of peritoneal carcinomatosis: a meta-analysis","volume":"38","author":"Chang","year":"2013","journal-title":"Clin Nucl Med"},{"issue":"7","key":"10.1016\/j.clinimag.2021.12.007_bb0245","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nrclinonc.2010.47","article-title":"Imaging ovarian cancer and peritoneal metastases\u2013current and emerging techniques","volume":"7","author":"Kyriazi","year":"2010","journal-title":"Nat Rev Clin Oncol"},{"issue":"5","key":"10.1016\/j.clinimag.2021.12.007_bb0250","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.2214\/AJR.07.2083","article-title":"Benign nonphysiologic lesions with increased 18F-FDG uptake on PET\/CT: characterization and incidence","volume":"189","author":"Metser","year":"2007","journal-title":"AJR Am J Roentgenol"},{"issue":"10","key":"10.1016\/j.clinimag.2021.12.007_bb0255","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1007\/s00259-004-1577-y","article-title":"Value of 18F-FDG PET in the detection of peritoneal carcinomatosis","volume":"31","author":"Suzuki","year":"2004","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"10.1016\/j.clinimag.2021.12.007_bb0260","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ejrad.2007.11.032","article-title":"Detection of histologically proven peritoneal carcinomatosis with fused 18F-FDG-PET\/MDCT","volume":"69","author":"Dirisamer","year":"2009","journal-title":"Eur J Radiol"},{"issue":"1","key":"10.1016\/j.clinimag.2021.12.007_bb0265","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1006\/gyno.2000.5738","article-title":"Whole-body PET with (fluorine-18)-2-deoxyglucose for detecting recurrent primary serous peritoneal carcinoma: an initial report","volume":"77","author":"Wang","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.clinimag.2021.12.007_bb0270","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1007\/s003300100998","article-title":"Peritoneal carcinomatosis","volume":"11","author":"Raptopoulos","year":"2001","journal-title":"Eur Radiol"},{"issue":"6","key":"10.1016\/j.clinimag.2021.12.007_bb0275","doi-asserted-by":"crossref","DOI":"10.2214\/AJR.09.2936","article-title":"Spectrum of (18)F-FDG PET\/CT appearances in peritoneal disease","volume":"193","author":"Anthony","year":"2009","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"10.1016\/j.clinimag.2021.12.007_bb0280","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00261-011-9722-0","article-title":"Extraovarian primary peritoneal carcinoma: staging with 18F-FDG PET\/CT","volume":"37","author":"Rakheja","year":"2012","journal-title":"Abdom Imaging"},{"issue":"6","key":"10.1016\/j.clinimag.2021.12.007_bb0285","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.3892\/ol.2016.4525","article-title":"Primary peritoneal serous carcinoma, an extremely rare malignancy: a case report and review of the literature","volume":"11","author":"Yun","year":"2016","journal-title":"Oncol Lett"},{"issue":"1","key":"10.1016\/j.clinimag.2021.12.007_bb0290","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1006\/gyno.2001.6246","article-title":"Positive emission tomography for evaluating a complete clinical response in patients with ovarian or peritoneal carcinoma: correlation with second-look laparotomy","volume":"82","author":"Rose","year":"2001","journal-title":"Gynecol Oncol"},{"issue":"7","key":"10.1016\/j.clinimag.2021.12.007_bb0295","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.radcr.2020.04.001","article-title":"Imaging features of primary peritoneal serous carcinoma: a case report","volume":"15","author":"Oh","year":"2020","journal-title":"Radiol Case Rep"},{"issue":"4","key":"10.1016\/j.clinimag.2021.12.007_bb0300","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2005.02.4067","article-title":"Randomized study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group comparing quality of life in patients with ovarian cancer treated with cisplatin\/paclitaxel versus carboplatin\/paclitaxel","volume":"24","author":"Greimel","year":"2006","journal-title":"J Clin Oncol"},{"issue":"Suppl 2","key":"10.1016\/j.clinimag.2021.12.007_bb0305","first-page":"144","article-title":"Long-term follow-up confirms a survival advantage of the paclitaxel-cisplatin regimen over the cyclophosphamide-cisplatin combination in advanced ovarian cancer","volume":"13","author":"Piccart","year":"2003","journal-title":"Int J Gynecol Cancer"},{"issue":"22","key":"10.1016\/j.clinimag.2021.12.007_bb0310","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1093\/jnci\/djh323","article-title":"Phase III randomized trial of docetaxel-carboplatin versus paclitaxel-carboplatin as first-line chemotherapy for ovarian carcinoma","volume":"96","author":"Vasey","year":"2004","journal-title":"J Natl Cancer Inst"},{"issue":"27","key":"10.1016\/j.clinimag.2021.12.007_bb0315","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1200\/JCO.19.00671","article-title":"Role of intraperitoneal therapy in the initial management of ovarian cancer","volume":"37","author":"Armstrong","year":"2019","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.clinimag.2021.12.007_bb0320","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJMoa052985","article-title":"Intraperitoneal cisplatin and paclitaxel in ovarian cancer","volume":"354","author":"Armstrong","year":"2006","journal-title":"N Engl J Med"},{"issue":"26","key":"10.1016\/j.clinimag.2021.12.007_bb0325","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1056\/NEJMoa1104390","article-title":"Incorporation of bevacizumab in the primary treatment of ovarian cancer","volume":"365","author":"Burger","year":"2011","journal-title":"N Engl J Med"},{"issue":"26","key":"10.1016\/j.clinimag.2021.12.007_bb0330","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1056\/NEJMoa1103799","article-title":"A phase 3 trial of bevacizumab in ovarian cancer","volume":"365","author":"Perren","year":"2011","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.clinimag.2021.12.007_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2009.02.005","article-title":"Primary peritoneal carcinoma in a young woman with suspected endometriosis","volume":"92","author":"Banz","year":"2009","journal-title":"Fertil Steril"},{"issue":"10","key":"10.1016\/j.clinimag.2021.12.007_bb0340","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1056\/NEJMoa0908806","article-title":"Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer","volume":"363","author":"Vergote","year":"2010","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.clinimag.2021.12.007_bb0345","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ygyno.2009.03.018","article-title":"Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm","volume":"114","author":"Chi","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.clinimag.2021.12.007_bb0350","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3389\/fonc.2017.00177","article-title":"Radiation treatment in women with ovarian cancer: past, present, and future","volume":"7","author":"Fields","year":"2017","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.clinimag.2021.12.007_bb0355","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ygyno.2016.02.005","article-title":"Intensity modulated radiation therapy for recurrent ovarian cancer refractory to chemotherapy","volume":"141","author":"Chundury","year":"2016","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1016\/j.clinimag.2021.12.007_bb0360","doi-asserted-by":"crossref","first-page":"17172","DOI":"10.1038\/s41598-020-74356-7","article-title":"Clinical analysis of conformal and intensity-modulated radiotherapy in patients with recurrent ovarian cancer","volume":"10","author":"Yang","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.clinimag.2021.12.007_bb0365","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.tjog.2012.10.003","article-title":"Prognosis for advanced-stage primary peritoneal serous papillary carcinoma and serous ovarian cancer in Taiwan","volume":"52","author":"Chao","year":"2013","journal-title":"Taiwan J Obstet Gynecol"}],"container-title":["Clinical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899707121004721?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899707121004721?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:48:14Z","timestamp":1760269694000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0899707121004721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":73,"alternative-id":["S0899707121004721"],"URL":"https:\/\/doi.org\/10.1016\/j.clinimag.2021.12.007","relation":{},"ISSN":["0899-7071"],"issn-type":[{"value":"0899-7071","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary peritoneal serous carcinoma: a primer for radiologists","name":"articletitle","label":"Article Title"},{"value":"Clinical Imaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinimag.2021.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}